Abstract

Incubation of rat glomerular mesangial cells with potent proinflammatory cytokines like interleukin 1 β (IL-1 β) triggers the expression of a non-pancreatic secretory phospholipase A 2 (sPLA 2) and increases the formation of prostaglandin E 2. We show here that sPLA 2 acts in an autocrine fashion on mesangial cells and induces a rapid activation of protein kinase C (PKC) isoenzymes δ and ϵ and of p42 mitogen-activated protein kinase (MAPK), two putative activators of cytosolic phospholipase A 2 (cPLA 2). sPLA 2 also activates Raf-1 kinase in mesangial cells which integrates the signals coming from PKC for further processing along the MAPK cascade. Subsequently a phosphorylation and activation of cPLA 2 is observed, thus arguing for a cross-talk between the two classes of PLA 2. Pretreatment of cells with either the highly specific PKC inhibitor Ro-318220 or the highly specific MAPK kinase (MEK) inhibitor PD 98059 completely blocked the sPLA 2-induced cPLA 2 activation, indicating that both kinases are essential for the cross-talk between the two types of PLA 2. The effect of sPLA 2 is mimicked by lysophosphatidylcholine (LPC), a reaction product of sPLA 2 activity. LPC stimulates PKC- ϵ, Raf-1 kinase and MAPK activation as well as cPLA 2 activation with a subsequent increase in arachidonic acid release from mesangial cells. These data suggest that sPLA 2 by cleaving membrane phospholipids and generating LPC and other lysophospholipids activates cPLA 2 via the PKC/Raf-1/MAPK signalling pathway. Hence a network of interactions between different PLA 2s is operative in mesangial cells and may contribute to the progression of glomerular inflammatory processes.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.